Cytotoxic mechanisms by M239V presenilin 2, a little-analyzed Alzheimer's disease causative mutant

被引:11
作者
Abe, Y
Hashimoto, Y
Tomita, Y
Terashita, K
Aiso, S
Tajima, H
Niikura, T
Matsuoka, M
Nishimoto, I
机构
[1] Keio Univ, Sch Med, Dept Pharmacol, Shinjuku Ku, Tokyo 1608582, Japan
[2] Keio Univ, Sch Med, Dept Anat, Tokyo 1608582, Japan
关键词
presenilin; 2; neuronal cell death; NADPH; oxidase; xanthine oxidase; G protein; Humanin;
D O I
10.1002/jnr.20163
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although neurotoxic functions are well characterized in familial Alzheimer's disease (FAD)-linked N141I mutant of presenilin (PS)2, little has been known about M239V-PS2, another established FAD-causative mutant. We found that expression of M239V-PS2 caused neuronal cytotoxicity. M239V-PS2 exerted three forms of cytotoxicity: one was sensitive to both an antioxidant glutathione-ethyl-ester (GEE) and a caspase inhibitor Ac-DEVD-CHO (DEVD); the second was sensitive to GEE but resistant to DEVD; and the third was resistant to both. The GEE/DEVD-sensitive cytotoxicity by M239V-PS2 was likely through NADPH oxidase and the GEE-sensitive/DEVD- resistant cytotoxicity through xanthine oxidase (XO). Both mechanisms by M239V-PS2 were suppressed by pertussis toxin (PTX) and were mediated by Galpha(o), but not by Galpha(i). Although Abeta1-43 itself induced no cytotoxicity, Abeta1-43 potentiated all three components of M239V-PS2 cytotoxicity. As these cytotoxic mechanisms by M239V-PS2 are fully shared with N14I-PS2, they are most likely implicated in the pathomechanism of FAD by PS2 mutations. Notably, cytotoxicity by M239V-PS2 could be inhibited by the combination of two clinically usable inhibitors of superoxide-generating enzymes, apocynin and oxypurinol. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:583 / 595
页数:13
相关论文
共 61 条
[1]  
Araki W, 2000, ANN NY ACAD SCI, V920, P241
[2]   A sensitive method to assay the xanthine oxidase activity in primary cultures of cerebellar granule cells [J].
Atlante, A ;
Valenti, D ;
Gagliardi, S ;
Passarella, S .
BRAIN RESEARCH PROTOCOLS, 2000, 6 (1-2) :1-5
[3]   A femtomolar-acting neuroprotective peptide [J].
Brenneman, DE ;
Gozes, I .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (10) :2299-2307
[4]   Characterization of human presenilin 1 transgenic rats: Increased sensitivity to apoptosis in primary neuronal cultures [J].
Czech, C ;
Lesort, M ;
Tremp, G ;
Terro, F ;
Blanchard, V ;
Schombert, B ;
Carpentier, N ;
Dreisler, S ;
Bonici, B ;
Takashima, A ;
Moussaoui, S ;
Hugon, J ;
Pradier, L .
NEUROSCIENCE, 1998, 87 (02) :325-336
[5]   ROLE OF XANTHINE-OXIDASE INHIBITOR AS FREE-RADICAL SCAVENGER - A NOVEL MECHANISM OF ACTION OF ALLOPURINOL AND OXYPURINOL IN MYOCARDIAL SALVAGE [J].
DAS, DK ;
ENGELMAN, RM ;
CLEMENT, R ;
OTANI, H ;
PRASAD, MR ;
RAO, PS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 148 (01) :314-319
[6]   Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury [J].
Dodd-O, JM ;
Pearse, DB .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (01) :H303-H312
[7]   Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity [J].
Dore, S ;
Kar, S ;
Quirion, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4772-4777
[8]   TRANSGENIC ANIMAL-MODELS FOR ALZHEIMERS-DISEASE [J].
FUKUCHI, KI ;
OGBURN, CE ;
SMITH, AC ;
KUNKEL, DD ;
FURLONG, CE ;
DEEB, SS ;
NOCHLIN, D ;
SUMI, SM ;
MARTIN, GM .
ALZHEIMERS DISEASE: AMYLOID PRECUSOR PROTEINS, SIGNAL TRANSDUCTION, AND NEURONAL TRANSPLANTATION, 1993, 695 :217-223
[9]   Neurite outgrowth induced by cyclic AMP can be modulated by the α subunit of Go [J].
Ghil, SH ;
Kim, BJ ;
Lee, YD ;
Suh-Kim, H .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (01) :151-158
[10]   G protein beta gamma complex-mediated apoptosis by familial Alzheimer's disease mutant of APP [J].
Giambarella, U ;
Yamatsuji, T ;
Okamoto, T ;
Matsui, T ;
Ikezu, T ;
Murayama, Y ;
Levine, MA ;
Katz, A ;
Gautam, N ;
Nishimoto, I .
EMBO JOURNAL, 1997, 16 (16) :4897-4907